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Abstract
Classiﬁcation of bloodstream infections (BSIs) as community-acquired (CA), healthcare-associated (HCA) and hospital-acquired (HA) has
been proposed. The epidemiology and clinical features of BSI according to that classiﬁcation in tertiary-care (TH) and community (CH)
hospitals were investigated in a prospective cohort of 821 BSI episodes from 15 hospitals (ten TH and ﬁve CH hospitals) in Andalucı´a,
Spain. Eighteen percent were CA, 24% were HCA and 58% were HA. The incidence of CA and HCA BSI was higher in CH than in TH
(CA: 3.9 episodes per 1000 admissions vs. 2.2, p <0.01; HCA: 5.0 vs. 2.9, p <0.01), whereas the incidence of HA BSI was lower (7.7 vs.
8.7, p <0.01). In CA and HCA BSI, the respiratory tract was more frequently the source in CH than in TH (CA: 30% vs. 15%; HCA: 20%
vs. 9%, p £0.03). In HCA BSI, chronic renal insufﬁciency and tunnelled catheters were less frequent in CH than in TH (11% vs. 26% and
7% vs. 19%, p £0.03), although chronic ulcers were more frequent (22% vs. 8%, p 0.008). BSIs as a result of methicillin-resistant Staphylo-
coccus aureus or Pseudomonas aeruginosa were very rare in CA episodes, although extended-spectrum b-lactamase-producing Escherichia
coli (ESBLEC) caused a similar proportion of all BSIs in CA, HCA and HA episodes. Multivariate analysis revealed no signiﬁcant difference
in mortality rates in CH and TH. HCA infections should be considered as a separate class of BSI in both TH and CH, although differences
between hospitals must be considered. CA BSIs were not caused by multidrug-resistant pathogens, except for ESBLEC.
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Introduction
Bloodstream infections (BSI) are an important cause of mor-
bidity and mortality in hospitalized patients [1–3]. Tradition-
ally, BSI have been divided into community and nosocomial
episodes [4]. However, subsequent to the implementation of
ambulatory alternatives to inpatient care, signiﬁcant changes
in the epidemiology of BSI have been noted and a proposal
was made to further subdivide community-onset BSI into
healthcare-associated (HCA) episodes for patients with sig-
niﬁcant recent healthcare contact and procedures, and
strictly community-acquired (CA) episodes for patients
without [5].
ª2010 The Authors
Journal Compilation ª2010 European Society of Clinical Microbiology and Infectious Diseases
ORIGINAL ARTICLE EPIDEMIOLOGY
However, this new classiﬁcation has been evaluated in
only a few studies [5–9], in which HCA episodes were
shown to be somewhat more similar to hospital-acquired
(HA) than to CA BSI in aetiology and predisposing condi-
tions; these studies included retrospective analysis or
included cases from a limited number of hospitals, and used
different criteria. Its applicability to both tertiary-care hospi-
tals and community hospitals has not been studied speciﬁ-
cally, nor is it known whether this classiﬁcation is helpful in
identifying patients with a low risk of acquiring some emer-
gent community-onset infection-causing, antibiotic-resistant
pathogens, such as extended-spectrum b-lactamase
(ESBL)-producing Escherichia coli [10]. The present study
aimed to investigate the population-based incidence, epidemi-
ology, aetiology and clinical features of BSI according to the
epidemiological type of infection, and to evaluate the newly-
proposed scheme within a wide sample of hospitals that
included both tertiary-care and community settings.
Materials and Methods
Site and design
A multicentre prospective cohort study was conducted in 15
public hospitals (ten tertiary-care and ﬁve community hospi-
tals) in Andalucı´a, Spain. The participating hospitals provide
health care to >90% of their catchment areas (>4 million)
[11].
All episodes of clinically signiﬁcant BSI in adult patients
(>14 years) between 15 October 2006 and 15 December
2006 were included. Because the aim of the study was to
include a signiﬁcant number of cases from community cen-
tres, the study period was extended until 15 March 2007 in
these hospitals.
Blood cultures were performed, processed and inter-
preted in accordance with the recommendations of the
Spanish Society of Infectious Diseases and Clinical Microbiol-
ogy [12]. Blood cultures (at least two blood draws) were
obtained from peripheral veins, except in a few cases where
the central venous catheter was the suspected cause, when
at least one blood draw was obtained from a peripheral vein
and another from the catheter. Susceptibility results were
interpreted according to the CLSI recommendations [13]; in
this analysis, we focussed on methicillin resistance in Staphylo-
coccus aureus, vancomycin-resistance in enterococci, ESBL
production in E. coli and Klebsiella spp., and carbapenem
resistance in Enterobacteriaceae and Pseudomonas aeruginosa.
Cases were detected by daily review of blood culture
results. All patients with positive blood cultures were consid-
ered eligible. Different episodes occurring in the same
patients were included only when caused by different spe-
cies. For potential contaminants (coagulase-negative staphylo-
cocci, diphtheroids), only episodes in which the organism
had been isolated from two or more blood draws were
included [4,12]. Patients were followed until discharge or
death. The study was approved by the Ethics Committees of
the participating centres, which waived the need for obtain-
ing informed consent.
Variables and deﬁnitions
The data collected included: type of hospital; epidemiologic
type of infection (CA, HCA or HA); demographics; type and
severity of chronic underlying disease [14]; source of BSI
(see below); vascular or urinary catheter and mechanical ven-
tilation at onset, endoscopic procedures performed within
the preceding week, and major surgery in the preceding
3 months; antimicrobial use; aetiology; empirical therapy and
outcome.
Episodes were classiﬁed as HA if the episode occurred
more than 48 h after admission [4]; all other episodes were
considered community-onset, which were then classiﬁed as
HCA or CA, according to the criteria used by Friedman
et al. [5]. In brief, episodes were classiﬁed as HCA when any
of the following was present: intravenous therapy or special-
ist nursing care at home, haemodialysis in the 30 days before
the BSI; hospitalization for >2 days in an acute care hospital
in the 90 days before the BSI; or resident status in a nursing
home or long-term care facility.
The BSI source was determined from clinical and labora-
tory data, using CDC criteria for secondary BSI [4]. Empiri-
cal therapy was considered appropriate when an active
antimicrobial agent (according to susceptibility data) was
administered at recommended doses within the ﬁrst 24 h
after the blood cultures were performed. Crude mortality
was recorded at days 14 and 30.
Statistical analysis
Population-based incidence rates were calculated according
to the assigned reference population for each centre [15]
and extrapolated for 1 year. The reference populations are
deﬁned by speciﬁc geographic limits; patients needing hospital
admission are initially hospitalized in their corresponding
centre and are only transferred to reference centres when
needed. A comparison of rates was performed using a Pois-
son regression model. Comparisons between CA and HCA,
and between HCA and HA episodes were performed simi-
larly to previously reported methods [5]; variables included
in the deﬁnitions were not compared. Similar methods were
used for comparisons between tertiary-care and community
hospitals. Categorical and continuous variables were com-
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pared using Fisher’s exact test and the the Mann–Whitney
U-test, respectively. Whenever a signiﬁcant crude association
was found between the type of hospital and mortality, a mul-
tivariate analysis was performed by logistic regression to
control for confouders using a stepwise forward method.
Results
Incidence of BSI and epidemiological type of infection
During the study period, 821 BSI episodes in adults were
included; 660 (80%) occurred in tertiary-care hospitals and
161 (20%) occurred in community hospitals. Overall, 476
(58%) were classiﬁed as HA, 195 (24%) as HCA, and 150
(18%) as CA. The distribution of BSI according to
pre-deﬁned epidemiological types of infection was somewhat
different in the two types of hospitals; compared to tertiary
hospitals, there was a higher frequency of CA episodes in
community centres (25% vs. 17%, p 0.01), a lower frequency
of HA episodes (47% vs. 60%, p 0.002) and a similar fre-
quency of HCA episodes (28% vs. 23%, p 0.1). The incidence
of BSIs is shown in Table 1. The overall population-based
incidence was higher in tertiary-care centres related to the
higher incidence of nosocomial episodes; the admissions-
based incidence was higher in community hospitals. Because
only ﬁve patients had been admitted from other centres out-
side their catchment area, the exclusion of these patients
from the analysis did not change the results.
Of patients with HCA episodes, 131 (67%) had been pre-
viously admitted, 28 (14%) were residents in long-term care
facilities, 28 (14%) were receiving haemodialysis and two
(1%) were receiving peritoneal dialysis, 41 (21%) attended a
day hospital, four (2%) received home intravenous therapy,
and ﬁve (3%) were receiving other types of specialized home
care (several patients had more than one of these predispos-
ing factors).
Predisposing features, sources and outcome according to
epidemiological type of infection
Table 2 shows patient characteristics, clinical features and
the outcome of BSI. Chronic renal insufﬁciency, haematologi-
cal cancer and neutropenia were more frequent in patients
with HCA than in CA BSI. Compared to HA episodes, HCA
occurred more frequently in patients with chronic renal
insufﬁciency, liver disease and cutaneous ulcer, whereas pre-
vious antibiotic use and invasive procedures (with the excep-
tion of tunnelled venous catheters) were more frequent in
patients with HA BSI. With regard to the source of infection,
urinary tract infection was more frequent in CA episodes
than in HCA BSI. Endocarditis was more frequent in HCA
than in HA cases, whereas vascular catheter-related infec-
tions were more frequent in HA BSI. Inappropriate empirical
therapy was more frequent in HA BSI. Although there was a
TABLE 1. Population-based and admissions-based incidence







Episodes per 100 000 population/year
All episodes 109.2 116.4a 75.3
CA 19.2 19.2 18.0
HCA 25.2 25.2 27.3
HA 64.8 72.0a 30.0
Episodes per 1000 admissions
All episodes 14.7 13.9a 16.8
CA 2.7 2.2a 3.9
HCA 3.5 2.9a 5.0
HA 8.4 8.7a 7.7
CA, community-acquired; HCA, healthcare associated; HA, hospital-acquired.
aFor comparison with community hospitals, p <0.01.
TABLE 2. Patient characteristics, clinical features and








Age in years, median (IQ range) 67 (46–77) 69 (56–70) 66 (53–75)
Male gender 80 (53) 116 (60) 286 (60)
Nonfatal underlying disease 106 (71)a 91 (47) 326 (68)
Chronic renal insufﬁciency 5 (3)a 33 (17)b 42 (9)
Chronic liver disease 17 (11) 26 (13)b 31 (7)
Solid cancer 21 (14) 34 (17) 112 (24)
Haematological cancer 4 (3)a 24 (12) 43 (9)
HIV infection 6 (4) 5 (3) 5 (1)
Chronic cutaneous ulcer –c 12 (6)d 9 (2)
Neutropenia 2 (1)a 13 (7) 32 (7)
Nontunnelled central venous catheter – 4 (2)b 182 (38)
Tunnelled venous catheter – 32 (16)b 35 (7)
Urinary catheter 19 (13) 25 (13)b 238 (50)
Mechanical ventilation – 1 (1)b 93 (20)
Endoscopic procedure 1 (1) 1 (1)b 28 (6)
Surgery – 9 (5)b 106 (22)
Previous antimicrobials 26 (17)a 62 (32)b 253 (53)
Source
Unknown 22 (15) 45 (23) 127 (27)
Urinary tract 46 (31)a 41 (21) 73 (15)
Respiratory tract 28 (19) 22 (11) 55 (12)
Intra-abdominal infection 15 (10) 22 (11) 44 (9)
Biliary tract 18 (12) 18 (9) 26 (5)
Endocarditis 8 (5) 9 (5)b 6 (1)
Skin and skin structures 8 (5) 10 (5) 21 (4)
Vascular catheter – 24 (12)b 116 (24)
Others 5 (3) 4 (2) 8 (2)
Appropriate empirical therapy 115 (77)b 141 (72)b 296 (62)
Mortality
14-day 22 (15) 36 (18) 97 (20)
30-day 29 (19) 43 (22) 116 (24)
Data are expressed as the number of cases (%), except where speciﬁed. p value
for all statistical comparisons ‡0.05, except where speciﬁed.
CA, community-acquired. HCA, healthcare-associated. HA, hospital-acquired.
a For comparison with healthcare-associated episodes, p <0.01 (Fisher’s exact
test).
bFor comparison with hospital-acquired episodes, p £0.01 (Fisher’s exact test).
cFor comparison with healthcare-associated episodes, p 0.02 (Fisher’s exact
test).
dFor comparison with hospital-acquired episodes, p 0.04 (Fisher’s exact test).
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trend toward higher mortality in HCA and HA episodes,
these differences were not statistically signiﬁcant.
Aetiology and antimicrobial susceptibility
The microorganisms causing BSI are shown in Table 3. Over-
all, Gram-negatives were more frequent in HCA than in CA
and HA infections. S. aureus, coagulase-negative staphylo-
cocci, Enterococcus spp., Enterobacter spp. and P. aeruginosa
were less frequent in CA infections, whereas Staphylococcus
pneumoniae and E. coli were more frequently associated with
this group. None of the CA cases were caused by methicillin-
resistant S. aureus, Stenotrophomonas maltophilia or Acinetobac-
ter baumannii, and only one by P. aeruginosa. By contrast, the
percentages of isolates producing ESBLs among E. coli or Kle-
bsiella spp. were similar among CA, HCA and HA BSI. There
were no episodes as a result of vancomycin-resistant entero-
cocci or carbapenem-resistant Enterobactericeae.
Analysis of BSI by hospital type
Among patients with CA episodes (40 from community hos-
pitals and 110 from tertiary hospitals), there were no signiﬁ-
cant differences in demographics, underlying conditions,
predisposing factors, source, microorganisms or mortality
by type of hospital (data not shown), with the following
exceptions: the respiratory tract was a more frequent source
in community centres (30% vs. 15%, p 0.01), whereas endo-
carditis was rather less frequent (0 vs. 7%, p 0.07); E. coli
was less frequent in community centres (23% vs. 44%,
p 0.01), whereas S. pneumoniae was more frequent (28% vs.
15%, p 0.06).
More differences were found in patients with HCA epi-
sodes (45 from community and 150 from tertiary-care hospi-
tals). Chronic renal insufﬁciency was less frequent in
community centres (11% vs. 26%, p 0.03) and chronic cuta-
neous ulcers were more frequent (22% vs. 8%, p 0.008).
Tunnelled venous catheters were more frequent in tertiary-
care centres (19% vs. 7%, p 0.04), as was haemodialysis (18%
vs. 2%, p 0.008). The respiratory tract was the most frequent
source of BSI in community hospitals (20% vs. 9%, p 0.03).
Mortality at day 14 was higher in community centres (16%
vs. 29%, p 0.03). However, the difference was no longer sta-
tistically signiﬁcant when adjusted for presentation with
severe sepsis or septic shock, source of infection and sever-
ity of underlying disease (adjusted OR 2.5, 95% CI 0.8–6.9,
p 0.1). There was no signiﬁcant difference in mortality at day
30 (20% vs. 13%, p 0.2).
For patients with HA episodes (76 from community cen-
tres and 400 from tertiary hospitals), the following differ-
ences were found: haematological cancer and neutropenia
were more frequent in tertiary-care centres (11% vs. 1%,
p 0.01, and 8% vs. 1%, p 0.04); venous catheters were also
more frequent (90% vs. 73%, p <0.001) but previous endo-
scopic procedures were less frequent (5% vs. 12%, p 0.01).
Skin and soft tissue infections were the most frequent
source of BSI in tertiary-care hospitals (21% vs. 0, p 0.04),
whereas urinary tract and intra-abdominal infections were
less frequent (14% vs. 24%, p 0.02, and 7% vs. 20%,
p <0.001). There were no signiﬁcant differences in aetiology
or mortality.
Discussion
The consideration of HCA as a speciﬁc category of BSI has
been found to be clinically relevant in the few studies
addressing the issue that we are aware of [5–9] because it
was discovered to be more similar to HA than to CA epi-
sodes with respect to underlying conditions and aetiology.
We were interested in investigating whether the HCA cate-
gory was just as relevant in a broader sample of hospitals
that included tertiary-care and community hospitals. We
TABLE 3. Microorganisms isolated from blood cultures, by







Gram-positive 67 (45) 74 (38)a 240 (50)
Staphylococcus aureus 10 (7) 22 (11) 67 (14)
Methicillin-resistant S. aureusb 0c 6 (3%) 24 (5%)
Coagulase-negative staphylococci 8 (5) 20 (10)a 118 (25)
Enterococcus 5 (3) 8 (4)a 47 (10)
Streptococcus pneumoniae 27 (18)d 11 (6)a 3 (<1)
Gram-negative 85 (57) 124 (64)a 237 (50)
Escherichia coli 57 (38) 72 (37)a 96 (20)
ESBL-producing E. colie 5 (3) 6 (3) 18 (4)
Klebsiella spp. 12 (8) 13 (7) 39 (8)
ESBL-producing Klebsiella spp.f 1 (<1) 1 (<1) 3 (<1)
Enterobacter spp. 1 (<1) 8 (4) 17 (4)
Pseudomonas aeruginosag 1 (<1)d 13 (7) 26 (5)
Acinetobacter baumannii 0 2 (1) 23 (5)
Stenotrophomonas maltophilia 0 1 (<1) 5 (1)
Anaerobes 4 (3) 3 (2) 6 (1)
Fungi 0 1 (1)h 15 (3)
Polymicrobial bacteraemia 12 (8) 10 (5) 38 (8)
Data are expressed as the number of cases (%), except where speciﬁed. The
p value for all statistical comparisons ‡0.05, except where speciﬁed.
CA, community-acquired; HCA, healthcare associated; HA, hospital-acquired.
aFor comparison with hospital-acquired episodes, p £0.01 (Fisher’s exact test).
bMethicillin-resistant isolates were 0, 27% and 36% of all S. aureus in CA, HCA
and HA bloodstream infection (BSI), respectively.The p value for CA vs. HA
was 0.02 (Fisher’s exact test).
cFor comparison with healthcare-associated episodes, p 0.03 (Fisher’s exact
test).
dFor comparison with healthcare-associated episodes, p £0.01 (Fisher’s exact
test).
eExtended-spectrum b-lactamase (ESBL)-producing isolates were 9%, 8% and
19% of all E. coli in CA, HCA, and HA BSI, respectively. The p value for HCA
vs. HA was 0.05 (Fisher’s exact test).
fESBL-producing isolates were 8% of all Klebsiella spp. in CA, HCA, and HA BSI.
gCarbapenem-resistant isolates were 0, 15% and 12% all P. aeruginosa in CA,
HCA, and HA BSI, respectively. The p value for HCA vs. HA was 0.05 (Fisher’s
exact test).
hFor comparison with hospital-acquired episodes, p 0.04 (Fisher’s exact test).
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used the criteria empirically developed by Friedman et al. [5]
because they have been shown to be of prognostic impor-
tance [5,8] and predictive of ineffective initial therapy [16].
Twenty-four percent of BSI infections reported in this
multicentre study including public tertiary-care and commu-
nity hospitals in Andalucı´a, Spain, were of the HCA type.
This is a similar ﬁgure to that reported by Valle´s et al. [8] in
their study performed in two teaching hospitals in Barcelona
(24.5%), and lower than that reported by Friedman et al. [5]
in four hospitals in North Carolina (37%), using similar deﬁ-
nitions. Most of our HCA BSI patients had recently been
admitted to an acute care hospital, and some were residents
in a long-term care facility or receiving haemodialysis. The
frequency of BSI in patients with ambulatory intravenous
treatment or specialized home care was low, whereas it was
much higher in North Carolina [5]. This probably reﬂects
signiﬁcant differences between the Spanish and US healthcare
systems inﬂuencing the epidemiology of BSI. We found that
the percentage of HCA episodes was similar in community
and tertiary-care centres, indicating that this is a category
of BSI that should be taken into account in both types of
hospitals.
The data obtained in the present study conﬁrm that HCA
and CA BSIs show signiﬁcant differences that physicians
attending patients in the emergency room should bear in
mind when attending patients with community-onset sepsis
[5–9,17]. Beyond the features included in the deﬁnition for
HCA BSI, patients in this group more frequently showed
fatal underlying conditions, chronic renal insufﬁciency, haema-
tological cancer, previous antimicrobial treatment and an
unknown source of infection. More importantly, some typical
healthcare-associated antibiotic-resistant organisms, such as
P. aeruginosa or methicillin-resistant S. aureus (MRSA), were
not present or rare in CA episodes but should be consid-
ered in patients with a suspected HCA BSI (CA MRSA is still
anecdotal in Spain) [18]. Curiously, other antibiotic-resistant
organisms (such as ESBL producers among E. coli or K. pneu-
moniae) were found at similar frequencies in CA, HCA and
HA episodes, reﬂecting the fact that ESBL-producing entero-
bacteria are now signiﬁcant causes of CA BSI [10] and that
the criteria used to deﬁne an HCA episode are not useful
for ruling out these organisms in patients with community-
onset BSI.
As far as we are aware, the characteristics of patients with
HCA BSI episodes by type of hospital have not previously
been studied. Signiﬁcant differences were found between
HCA episodes occurring in tertiary-care and community cen-
tres, reﬂecting the type of outpatients cared for in both
types of centres. Thus, haemodialysis and tunnelled catheters
were more frequent in tertiary-care hospitals, whereas
patients with HCA BSI in community hospitals were mainly
recently admitted patients with chronic conditions or
patients with solid cancer receiving intravenous chemo-
therapy in a day hospital. There was a higher crude mortality
rate for HCA BSI patients treated in community centres
compared to tertiary-care hospitals, although the results of
the multivariate analysis suggest that the crude association
was confounded by other variables.
Although benchmark rates exists for HA BSI and total BSI
[1–3], we have provided incidence rates for HCA BSI.
Because the most appropriate denominator for HCA BSI (i.e.
the number of patients or patient-days at risk) is very difﬁ-
cult to obtain, we opted to provide both population-based
and admission-based rates. We consider population-based
rates to be more appropriate because not every patient with
HCA BSI is admitted to hospital. Because hospitals participat-
ing in the study attend >90% of patients in their catchment
area needing hospitalization, the population-based rates esti-
mated in the present study should be considered as mini-
mum rates.
The present study has several limitations. The number of
cases from community hospitals was lower compared to that
from tertiary-care centres, which limits the comparisons
between the two types of hospital. Also, the study period
was longer in the community hospitals and, because commu-
nity-onset BSI may show seasonal differences, this may have
inﬂuenced the results. However, the study periods were
chosen aiming to minimize the impact of the different
parameters. In addition, even though blood cultures were
processed in all centres using standardized protocols [12,13],
there may have been some differences among the hospitals.
Finally, the results obtained are probably not applicable to
areas with different a epidemiology of resistant bacteria (such
as endemic CA MRSA) and different healthcare systems.
In summary, HCA BSI should be considered as a distinct
class of BSI, in both tertiary-care and community hospitals,
although differences in the predisposing conditions of the
patients and clinical features should be taken into account.
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